Múltiples anormalidades del tronco cerebral serotoninérgico en el síndrome de muerte súbita infantil

David S Paterson1, Felicia L Trachtenberg, Eric G Thompson

  • 1Department of Pathology, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA. david.paterson@childrens.harvard.edu

JAMA
|November 2, 2006
PubMed
Resumen

Los casos de síndrome de muerte súbita infantil (SIDS) muestran un mayor recuento de neuronas de serotonina (5-HT) y una menor unión al receptor en la médula. Esto sugiere que la disfunción medular generalizada de 5-HT puede contribuir a la SMSL, particularmente en los hombres.

Videos de Conceptos Relacionados

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...